In vitro activity of trovafloxacin against Chlamydia pneumoniae
- PMID: 9303410
- PMCID: PMC164061
- DOI: 10.1128/AAC.41.9.2033
In vitro activity of trovafloxacin against Chlamydia pneumoniae
Abstract
The in vitro susceptibilities of 12 strains of Chlamydia pneumoniae to a new quinolone, trovafloxacin, and ofloxacin, doxycycline, erythromycin, and azithromycin were determined. The activity of trovafloxacin was similar to that of ofloxacin, with a MIC at which 90% of the isolates are inhibited and a minimal concentration at which 90% of the isolates are killed of 1.0 microg/ml, but trovafloxacin was less active than doxycycline, erythromycin, and azithromycin.
Similar articles
-
In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.Antimicrob Agents Chemother. 1998 Apr;42(4):951-2. doi: 10.1128/AAC.42.4.951. Antimicrob Agents Chemother. 1998. PMID: 9559818 Free PMC article.
-
In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae.Antimicrob Agents Chemother. 1999 Nov;43(11):2806-7. doi: 10.1128/AAC.43.11.2806. Antimicrob Agents Chemother. 1999. PMID: 10543770 Free PMC article.
-
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae.Antimicrob Agents Chemother. 1992 Jul;36(7):1573-4. doi: 10.1128/AAC.36.7.1573. Antimicrob Agents Chemother. 1992. PMID: 1324650 Free PMC article.
-
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.Antimicrob Agents Chemother. 1998 Oct;42(10):2747-8. doi: 10.1128/AAC.42.10.2747. Antimicrob Agents Chemother. 1998. PMID: 9756789 Free PMC article.
-
Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens.Eur J Clin Microbiol Infect Dis. 1998 Jun;17(6):405-12. doi: 10.1007/BF01691573. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9758283 Review.
Cited by
-
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.Antimicrob Agents Chemother. 1998 Jun;42(6):1515-6. doi: 10.1128/AAC.42.6.1515. Antimicrob Agents Chemother. 1998. PMID: 9624507 Free PMC article.
-
The new fluoroquinolones: A critical review.Can J Infect Dis. 1999 May;10(3):207-38. doi: 10.1155/1999/378394. Can J Infect Dis. 1999. PMID: 22346384 Free PMC article.
-
In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.Antimicrob Agents Chemother. 1998 Apr;42(4):951-2. doi: 10.1128/AAC.42.4.951. Antimicrob Agents Chemother. 1998. PMID: 9559818 Free PMC article.
-
In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae.Antimicrob Agents Chemother. 1999 Nov;43(11):2806-7. doi: 10.1128/AAC.43.11.2806. Antimicrob Agents Chemother. 1999. PMID: 10543770 Free PMC article.
-
Activity of quinolones against Chlamydia pneumoniae.Drugs. 1999;58 Suppl 2:78-81. doi: 10.2165/00003495-199958002-00015. Drugs. 1999. PMID: 10553711 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources